Sign In
Buy LFMD
$3.50
-0.140 (-3.85%)
At Close: Jul 31, 2026
LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team
08:00am, Monday, 16'th Mar 2026
NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of Atul Kavthekar as Chief Financial Offi
LifeMD: Wegovy Pill, Net Cash, And Low Multiple Sets Up Longs For Possible Alpha
03:39pm, Wednesday, 11'th Mar 2026
LifeMD is rated Buy, trading at a low 0.796x TTM sales, with upside if multiples revert. LFMD's strategic divestment of WorkSimpli refocused the business as a pure-play telehealth and pharmacy provide
Uniqure To Rally Around 92%? Here Are 10 Top Analyst Forecasts For Wednesday
08:19am, Wednesday, 11'th Mar 2026
Top Wall Street analysts changed their outlook on top names. See all changes on analyst ratings page.
LifeMD, Inc. (LFMD) Q4 2025 Earnings Call Transcript
06:37pm, Monday, 09'th Mar 2026
LifeMD, Inc. (LFMD) Q4 2025 Earnings Call Transcript
LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates
06:20pm, Monday, 09'th Mar 2026
LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.02 per share a year ago.
LifeMD Reports Fourth Quarter and Full Year 2025 Results
04:05pm, Monday, 09'th Mar 2026
Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million. Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.
LifeMD to Participate in Two Investor Conferences During March
04:05pm, Tuesday, 03'rd Mar 2026
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following in
LifeMD: Still My Favorite Bargain On The Market
02:21am, Thursday, 26'th Feb 2026
LifeMD remains a deeply undervalued telehealth stock, now trading with significant pessimism priced in after a 55% decline. LFMD's business model faces risks from slowing growth, legal issues, competi
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
08:00am, Monday, 23'rd Feb 2026
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 month
LifeMD: Pure Telehealth Play With In-House Pharmacy Integration
04:15pm, Monday, 02'nd Feb 2026
LifeMD is rated a buy with an FY 2026 target price of ~$6, implying over 85% upside from current levels. LFMD's shift to a pure-play telehealth model, divesting WorkSimpli, and integrating in-house ph
Analyzing LifeMD (NASDAQ:LFMD) & Avantor (NYSE:AVTR)
01:26am, Monday, 02'nd Feb 2026
Avantor (NYSE: AVTR - Get Free Report) and LifeMD (NASDAQ: LFMD - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the stren
Kuehn Law Encourages Investors of LifeMD, Inc. to Contact Law Firm
12:53pm, Wednesday, 28'th Jan 2026
NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of LifeMD, Inc. (NASDAQ: LFMD) breached their fi
LifeMD, Inc. (NASDAQ:LFMD) Given Consensus Rating of “Moderate Buy” by Brokerages
02:22am, Monday, 26'th Jan 2026
Shares of LifeMD, Inc. (NASDAQ: LFMD - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the nine ratings firms that are currently covering the company, Marketbeat repor
Kuehn Law Encourages Investors of LifeMD, Inc. to Contact Law Firm
09:56am, Thursday, 22'nd Jan 2026
New York, New York--(Newsfile Corp. - January 22, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of LifeMD, Inc. (NASDAQ: LFMD) b
LifeMD (NASDAQ:LFMD) vs. Concentra Group Holdings Parent (NYSE:CON) Financial Contrast
02:00am, Wednesday, 07'th Jan 2026
Concentra Group Holdings Parent (NYSE: CON - Get Free Report) and LifeMD (NASDAQ: LFMD - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies
